How Another Knee Surgery Hurts Parsons And His Mavs

Follow The Fan: Facebook | Twitter

DALLAS (105.3 THE FAN) - According to reports, Dallas Mavericks forward Chandler Parsons has a torn meniscus in his right knee and will likely undergo season-ending surgery.

If Chandler Parsons undergoes season-ending surgery on his right knee, the procedure will set in motion two major questions for the Mavs.

One is immediate: Dallas is 35-35 and vying for a postseason berth. "We're fighting for our playoff lives,'' Parsons recently said — and playing the final dozen games without a top player puts that goal in jeopardy.

Two is long-term, for while ESPN's initial report on Chandler's torn meniscus in his right knee includes a stated belief that there will be a full recovery for "his regular offseason workout routine,'' rehab from such  surgery can take three months. That would take Parsons to about July 1 - right at the time when he can opt out of his contract and become a free agent, with the Mavs able to keep him on a four-year deal worth $93.8 million or another bidder winning him at four years and $90 million.

Parsons, of course, has spent much of this season rounding back into form after the hybrid-microfracture surgery he underwent last May on this same knee. In the last two months, he's averaged about 19 points, six rebounds and three assists per game, looking healthy for a Mavs team trying to look competitive.

Now both of those accomplishments/potential accomplishments are joined by questions.

*This is a developing story. Listen to 105.3 The Fan for the latest information. 

(©2016 CBS Local Media, a division of CBS Radio Inc. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.